Georges Harik

Georges Harik

Palo Alto, California, United States United states
Investor
Member since June 07, 2007
16 Splash Points
26 followers
1 company followed
Following Followers
About Georges
Work/education
Activities
Following
Investor interests
Type of investor Angel
Investments made EQAL, MUBI, Miso, Telly, Humanoid, MyLikes, Mochi Media, Periscope, Loomia, IndieGoGo, Handipoints, ScanScout, Mesmo.tv, Socialcam, Meraki, WideOrbit, Love With Food, Inventables, Omnidrive, Plusmo, Momentum Machines, Octopart, Feedjit, ZocDoc, Justin.tv
Credentials Accredited Investor
Full bio

EQAL (acquired by Everyday Health)
MUBI (funded)                        
Miso (acquired by Dijit Media)
Humanoid (acquired by CloudFactory)     
MyLikes (funded)                        
Mochi Media (acquired by Shanda Games; $80M)
Periscope (funded)                        
Loomia (funded)                        
IndieGoGo (funded)                        
Handipoints (funded)                        
ScanScout (acquired by Tremor Video; $65M)
Mesmo.tv (funded)                        
Socialcam (acquired by Autodesk; $60M)
Meraki     (acquired by Cisco; $1.2B)                
WideOrbit (funded)                        
Love With Food (funded)                        
Inventables (funded)                        
Omnidrive (funded)                        
Plusmo (acquired by AT&T)
Momentum Machines (funded)                        
Octopart (funded)                        
Feedjit  (funded)                        
ZocDoc  (funded)                        
Justin.tv (funded)                        
23andMe (funded)                        
Stupeflix (funded)                        
Mogad (acquired by iSkoot)
ICON Aircraft (funded)                        
Platial (funded)                        
Venturebeat (funded)                        
Kaboodle (acquired by Hearst Corporation; $18M)
Vator.TV (funded)                        
Adchemy (funded)                        
Dermandar (funded)                        
Yamli (funded)                        
Adimab (funded)                        
Nextbio  (funded)                        
Buxfer (funded)